TipRanks
Go Ultimate55% OFF

Immunovant (IMVT) Market Cap & Net Worth

Immunovant Market Cap

Immunovant has a market cap or net worth of $6.03B as of Nov 01, 2026. Its market cap has increase by 40.05% in one year.

Market Cap
$6.03B
Enterprise Value
$7.12B
1-Year Change
40.05%
Category
Medium (2B-10B)
Stock Price
$29.17

Market Cap Chart

0.002.50B5.00B7.50B10.00BNov 21Nov 22Nov 23Nov 24Nov 25
Market Cap History
Download to Excel
IMVT market cap history
DateMarket Cap% Change
Oct 30, 20266.03B-1.59%
Oct 29, 20266.12B+0.75%
Oct 28, 20266.08B+1.87%
Oct 27, 20265.97B+2.52%
Oct 26, 20265.82B-0.84%
Oct 23, 20265.87B-2.37%
Oct 22, 20266.01B+2.54%
Oct 21, 20265.86B-0.73%
Oct 20, 20265.91B+3.51%
Oct 19, 20265.70B+3.33%
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Related stocks
CompanyMarket Cap
IMVT$6.03B
TGTX$9.36B
VRDN$2.79B
AUPH$2.22B
PTGX$9.37B
KYMR$10.81B